Molecular Mechanisms of the Actions of Brain Peptide-Containing Drugs: Cortexin
- 1 Downloads
This article considers new data on the key molecular mechanisms which may underlie the neuroprotective properties of multicomponent organ-specific medicinal formulations consisting of peptide hydrolysates extracted from animal brains. Such formulations, including cortexin, are currently quite widely used in the treatment of cerebral pathologies. The potential molecular mechanisms of the neuroprotective effects of cortexin are shown to be diverse and to influence key processes underlying neuroplasticity: signal transduction, energy metabolism, proteolytic modification of proteins, brain cell structures, and neuroinflammation processes. The pleiotropic nature of the mechanisms of action of cortexin results from the composition of the formulation, which contains a multitude of different neuropeptides. The tissue specificity of the molecular mechanisms identified here to a significant extent determines the efficacy of the agent in cerebral pathologies.
Keywordspeptide hydrolysates neuroplasticity cortexin
Unable to display preview. Download preview PDF.
- 6.I. P. Ashmarin, S. A. Chepurnov, and A. P. Kulaichev, “Cascade unidirectional regulatory processes of short-lived peptides,” Fiziol. Zh,, 75, No. 5, 627–632 (1989).Google Scholar
- 10.M. Yu. Stepanichev, M. V. Onufriev, D. I. Peregud, et al., “Effects of cortexin on free-radical oxidation and inflammatory processes in rats with normal and accelerated aging,” Neirokhimiya, 35, No. 2, 187–198 (2018), https://doi.org/ https://doi.org/10.7868/S1027813318020127.
- 11.V. A. Aniol, Yu. A. Novitskaya, T. N. Borodina, et al., “Assessment of the antiepileptic effects of cortexin in a model of convulsive activity,” Zh. Nevrol. Psikhiat., 111, No. 12, 68–73 (2011).Google Scholar
- 14.A. A. Yakovlev and N. V. Gulyaeva, “Possible role of proteases in preconditioning of brain cells to pathological conditions,” Biochemistry, 80, No. 2, 163–171 (2015), https://doi.org/ https://doi.org/10.1134/S00062979.15020030.
- 15.A. A. Yakovlev, A. A. Lyzhin, L. G. Khaspekov, et al., “Peptide drug cortexin inhibits brain caspase-8,” Biomed. Khim., 63, No. 1, 27–31 (2017), https://doi.org/ https://doi.org/10.18097/PBMC2017630127.